Legal notice according to § 12 (2 & 3) of the German Investment Act (Vermögensanlagengesetz): The purchase of this asset investment involves considerable risks and can lead to the complete loss of the deployed assets. The projected return is not guaranteed and may also be lower.
Investment key figures
Explanations on the company profile and interest rate - incl. interest rate calculator.Description
Description
Short description
Dietary supplements are experiencing an unprecedented boom worldwide – and for good reason: 65% of all working adults feel constantly fatigued. 8 out of 10 people report a lack of energy. More and more people want to actively support their health, regain their energy, increase their zest for life, and remain high-performing in the long term.
Supplements can make an important contribution to addressing this. Yet over 90% of the ingredients in conventional supplements go unused because they are poorly or not at all bioavailable. Customers pay for products that hardly reach the body – and therefore have little or no noticeable effect.

Until now. With our patented SoluSmart® absorption technology, we are redefining dietary supplements. It enhances the uptake of bioactive plant compounds, creating a clear difference compared to conventional formulations – efficient, natural, and scientifically validated, without exaggerated claims.

We explain exactly how our SoluSmart® absorption technology works in the chapter "Innovation and Technology".
Our mission: Maintain and restore performance and quality of life – in demanding professional routines, family life, leisure, and as we age.
This mission is rooted in our founding story: it began by supporting families of children living with a rare muscular disease (muscular dystrophy) that caused severe physical exhaustion. This experience profoundly shaped us – and showed how much potential our approach has to make bioactive compounds truly usable by the body. This very origin drives us today to combine natural solutions with modern technology like SoluSmart® – for noticeable improvements in everyday life for many people.

Affluent, enthusiastic customers „It feels like the clock is turning back – I’m getting my old fitness back.“……„The first supplement that actually works.“
Successful market launch: Organic growth without spending a single euro on paid advertising – an extraordinary proof of concept in the industry. Since our market entry with the iüVitalizer in Q1 2025, we have already sold over 1,600 products.

A market with enormous potential: The European supplement market is growing annually by 8.5% to over €50 billion. Premium products with scientific evidence are the clear trend.
Your opportunity: We combine technological leadership, a strong team with over 60 years of professional experience in medicine, pharma, natural product research, and biotech company development, and real customer results.
Seize the opportunity to become part of the iüLabs success story – and invest in noticeably better health.
Team
Dr. med. Wolfgang Brysch
CEO & Chief Scientific Officer
Dr. Dominik Pretz
Chief Operating Officer
Dr. Bob McDonald MD
Chief Medical Advisor
Emily Johnson
Marketing Manager UK
Product and Customer Benefits
The silent epidemic of exhaustion
65% of all working people feel permanently tired. 8 out of 10 people report a lack of energy. The billion-dollar supplement market has so far offered no effective answer. Until now.

With the iüVitalizer, we have developed a product that makes a real difference – because it addresses energy where it originates: in the cells. Our SoluSmart® technology significantly increases the bioavailability of selected bioactive ingredients and enables the body to absorb and utilize them more effectively.
We deliberately rely on natural, scientifically studied plant compounds such as quercetin from apples and onions, resveratrol from grapes, or extracts from rhodiola. These compounds have been the subject of intense research for years and are associated with numerous beneficial properties – however, what truly matters is how well the body can actually absorb them.
By combining high-quality raw materials with an advanced absorption technology, we create an approach that specifically supports energy metabolism at the cellular level and enables many users to experience noticeably more clarity, focus, and resilience in everyday life – precisely where conventional supplements often reach their limits.
iüVitalizer – When energy returns
Over 30 precisely balanced bioactive ingredients, formulated for cellular energy metabolism. Thanks to SoluSmart®, they reach the cells significantly better – noticeable effects from the very first dose.
Genuine customer voices
"My daughter got her life back thanks to the Vitalizer" – customer whose daughter suffered from chronic exhaustion.
"The first supplement I’ve stuck with – because I feel a clearly positive effect" – Mark Beaumont, world-record-holding endurance cyclist.
Growing product family
In addition to the iüVitalizer, we have successfully launched two other scientifically grounded products – each developed for key health needs:
- iüVitalizer – Cellular energy & exhaustion
- iüMove – Joints, mobility
- iüProtect – Immune system
- Product pipeline: menopause, sleep, long COVID
.jpg)
This means we already have an early, scalable portfolio that covers multiple relevant application areas and can be further expanded on a unified technology and brand foundation.
All products follow the same principle: SoluSmart® + scientific precision = noticeably better quality of life.
Innovation and technology
SoluSmart® – The revolution of bioavailability
The problem no one has been able to solve until now:
75 – 99% of plant compounds in standard supplements are water-insoluble and never reach their target tissues. Most of them are excreted unused.
SoluSmart® – When innovation meets nature
Microscopic multilamellar vesicles made exclusively from natural ingredients, structurally identical to human cell membranes. Our patented technology ensures that these vesicles form only during preparation – through a brief but targeted energy input when shaken or through preparation in the iüActivator, a specially developed mixing beaker with an integrated magnetic stirrer.

Within milliseconds, the bioactive plant compounds are freshly embedded into the SoluSmart® vesicles, resulting in millions of microscopic biotransporters (comparable to mini taxis). These can pass the gut with exceptional efficiency and reach the bloodstream significantly faster and at higher concentrations.
Why SoluSmart® is superior
- Significantly higher bioavailability than conventional products
- 100% natural raw materials
- Activation “on demand” – full potency of the ingredients is activated just before consumption
- 5- to 20-times higher loading capacity than classic liposomes (each vesicle can hold 5 to 20 times more bioactive compounds than conventional liposomes – meaning substantially more “payload” in every single transport unit)

SoluSmart® is patented, scientifically validated, and globally unique
With SoluSmart®, we hold a significant technological advantage in a billion-euro market. Competitors can only watch – you can invest.
Market and target audience
A market with strong tailwinds
The European supplement market is growing from €45.6 billion (2024) to an expected €93.2 billion (2033). The growth rate is 8.45% per year.
The central trend: premium products with evidence and noticeable effects.
Our core target groups
- Generation 40+: 76 million Europeans over 50 years old – financially strong, health-conscious, high quality expectations.
- Stressed professionals: Millions of people with chronic stress, high performance pressure, and low recovery.
- Women in menopause, people with sleep problems, athletes, Long COVID / ME/CFS.

Global scalability
The U.S. market, with over 65 billion USD, offers additional substantial long-term growth potential.
The question is not whether the market is big enough – but: How fast can we conquer it?
Competition and Unique Selling Points
The market is fragmented – thousands of providers, little innovation.
Conventional products rely almost exclusively on capsules, tablets, powders with minimal bioavailability.
iüLabs clearly stands out

Core advantage: Technology, bioavailability, and scientific depth that no competitor offers in a comparable way.
Business Model and Sales
DTC model (Direct-to-Consumer) via online shop (www.iulabs.de)
Maximum control over product quality, brand management, and customer experience – combined with high margins, rapid scalability, and global reach without intermediaries. This model has already proven highly effective for us: we have sold out multiple times, even as we continuously increased production. Strong demand confirms both the relevance of our approach and the efficiency of our direct distribution channel.

Scientific substance instead of classic advertising pressure
During the scale-up phase, we plan a dual expansion of our marketing activities. Our growth so far has been driven primarily by knowledge-sharing and earned content – especially through organic recommendations, podcast invitations, and independent media coverage. We will further expand this effective strategy, including targeted media outreach and popular science publications.
In addition, we are increasingly developing owned content: social media channels operated directly by iüLabs, for which we produce proprietary, high-quality content. A particular focus lies on scientifically grounded content that explains complex relationships in an accessible way and clearly differentiates us from purely promotional messaging. Through this form of trust marketing, we aim to further strengthen our community and expand our base of long-term, loyal customers.
The principle
Value through knowledge instead of advertising.
The effect:
Organic growth, high credibility, strong repurchase rate, and customer loyalty.
With additional marketing budget, we scale a model that has already proven its effectiveness.
Previous achievements
- 100% organic growth – entirely without paid advertising
- iüVitalizer sold out twice due to unexpectedly high demand
- Above-average repurchase rate of over 40% – significantly above the DTC industry average of approx. 30%
- Current CLV: 384 € – a strong indicator of long-term growth, high repurchase rates, and a clear product-market fit
- Strong media resonance and a continuously growing community
- Scientifically validated formulations and patented SoluSmart® technology

Conclusion: We are already experiencing above-average growth without a marketing budget – with additional capital for scalable campaigns, this growth can be significantly accelerated.
Goals and use of capital

- Marketing & brand building: Scaling social media, performance marketing, podcasts, and YouTube. Goal: stronger visibility, accelerated growth, international expansion.
- Production & supply chain: Production of larger batches, resulting in better purchasing prices and higher margins.
- 3. Team development: Targeted team expansion in marketing, operations, and finance without giving up lean structures.
- 4. Product development: New evidence-based formulations for sleep, menopause, long COVID, and energy. Scientific studies in cooperation with universities.
Top reasons to invest
- Patented technology leadership: Clear barriers to entry, scientific advantage, global intellectual property protection.
- Proven product-market fit with exceptional metrics: Organic growth, strong repurchases, high customer satisfaction.
- Excellent team with scientific and entrepreneurial experience: Medicine, biotechnology, nutritional science, entrepreneurship – combined in one team.
- High returns in a 50-billion-euro growth market: 50-billion-euro market, international potential, scalable D2C model.
- Measurable impact for millions of people: More energy, better health, and higher quality of life for millions. High added value for each individual and for society.
FAQ
What is SoluSmart® and why is this technology so crucial?
SoluSmart® is the patented core technology behind all iüLabs products. It significantly increases the absorption of bioactive ingredients in the body by forming freshly mixed, microscopic multilamellar vesicles. These consist of natural plant lipids and resemble the structure of human cell membranes.
When shaken or activated in the iüActivator, millions of these vesicles form within milliseconds, protecting the bioactive ingredients and transporting them efficiently through the intestinal wall. This allows them to reach the bloodstream faster and in higher concentrations – a decisive advantage over classic supplements with low bioavailability.
Learn more about SoluSmart® here.
What sets iüLabs products apart from other supplements?
iüLabs focuses on areas where many supplements fail – effectiveness, quality, and bioavailability. Our products stand out in four key areas:
Scientific expertise:
Our team consists of experienced physicians, biologists, and nutrition scientists with decades of research experience. This expertise enables evidence-based formulations that target genuine physiological effects.
Highest quality standards:
All raw materials are tested for purity, heavy metals, pesticides, and herbicides; production follows international GMP standards.
Patented SoluSmart® technology:
Our technology significantly increases the bioavailability of natural plant compounds by forming freshly mixed microscopic vesicles that transport active ingredients with exceptional efficiency.
Easy application & optimal tolerability:
The drink is freshly activated by shaking or with the iüActivator and is far better tolerated than tablets containing fillers and binders.
In short: iüLabs combines scientific precision, the highest quality standards, and technological differentiation – for noticeable results.
How does iüLabs differ strategically from other supplement brands?
We are not a classic “vitamin brand”; we develop technology-based health solutions built on a scientific platform (SoluSmart®). Every new ingredient that can be embedded in vesicles opens up a new product segment – from energy to immune function. This creates scalability, clear differentiation, and long-term competitive advantages.
How does iüLabs generate revenue, and what do the margins look like?
We operate in a DTC model with highly attractive single-purchase and subscription margins. Thanks to our proprietary technology platform and standardized formulations, scaling effects become possible, further increasing margins as volume grows.
How large is the market for energy, stress, and performance supplements?
The European supplement market exceeds €30 billion and continues to grow annually. Energy, stress, and mental performance are among the fastest-growing segments. Over 65% of working adults report chronic fatigue – representing enormous potential for solutions like the iüVitalizer.
How sustainable is iüLabs' growth?
Despite entirely organic growth, we achieve above-average repurchase rates (over 40%) and a strong customer lifetime value. The iüVitalizer has sold out twice without any marketing budget. This shows: sustainable growth arises from real impact and customer satisfaction – not advertising.
What role does SoluSmart® technology play for future products?
SoluSmart® is our scientific core platform. All existing products and pipeline formulations can be built on this technology. This creates scalability, differentiation, and long-term competitive advantages. Additionally, future licensing and partnership opportunities may arise.
How will the investment be used, and what is the goal for the next 18 months?
The capital will be used primarily for three areas:
- Expansion of marketing and community reach
- Scaling production (cost reduction and increased availability)
- Development of additional products based on our technology
The goal is to place iüLabs on a clear growth trajectory and become profitable in the medium term – supported by strong customer loyalty, patented technology, and a growing market.
Riskmanagement
Proactive safeguards for sustainable growth
Every growing company faces risks. iüLabs has identified these and implemented strategic measures.
Market and competitive risks
- Risk: New entrants.
- Our patented technological lead acts as a genuine barrier to entry: developing comparable absorption systems requires significant R&D resources, regulatory expertise, and knowledge in lipid technology. Additionally, we strengthen our position through continuous product optimization and independent scientific validation.
- Risk: Price pressure.
- Countermeasure: Through our clear premium positioning and functional added value, we differentiate ourselves from the mass market. Customers are not buying "another supplement," but a technology-based system with significantly enhanced bioavailability – a value that cannot be substituted by price alone.
Regulatory and compliance risks
- Risk: Changes in EU law.
- Countermeasure: We have long-standing experience in the pharmaceutical and food law environment and continuously monitor regulatory developments. Legislative changes are anticipated early, allowing formulations, labeling, or claims to be legally adjusted before they become a risk.
Supply chain risks
- Risk: Dependence on individual suppliers.
- Countermeasure: We deliberately work with multiple certified European manufacturers and raw material suppliers who can substitute for each other. Additionally, we maintain safety stocks for critical components such as lipids, extracts, and packaging materials to reliably cushion demand peaks and logistical delays.
Financial scaling risks
- Risk: Scaling pressure.
- Countermeasure: Our D2C model generates direct cash flow, which becomes even more stable through recurring subscription revenue. Strong unit economics allow growth to be financed cleanly in advance without relying on short-term liquidity. Moreover, the modular production model enables gradual scaling, where investments are only triggered once demand is predictable.
About iüLabs
It all began in 2014 with Felix, a young boy from England suffering from Duchenne muscular dystrophy (DMD) – a genetic muscle disease for which there is still no cure. His parents and other affected families, including Dr. Bob McDonald, searched worldwide for ways to improve their children’s quality of life. At a professional conference, they met Dr. Wolfgang Brysch, who at that time was researching a novel technology to enhance the absorption of natural plant compounds: SoluSmart®.

Using this technology, Dr. Wolfgang Brysch and his team subsequently developed a supplement designed to help children maintain their energy, mobility, and zest for life as effectively as possible. The positive effects observed in Felix and other DMD children were so pronounced that in 2021, iüLabs was founded – with the vision of making scientific innovation, natural compounds, and SoluSmart® accessible to everyone suffering from stress, exhaustion, and declining performance.
Today, iüLabs develops products that make a real difference – scientifically grounded, technologically leading, and noticeably effective in everyday life.
The full founding story can be found here.
Due Diligence Dataroom
Hier können Sie Zugriff auf den Due Diligence Datenraum des Unternehmens anfragen.
Für die Freigabe ist es erforderlich, dass Sie sich auf der FunderNation Plattform identifizieren. Die Identifikation können Sie hier durchführen.
Ihre Anfrage leiten wir an das Unternehmen weiter. Wird der Zugang bestätigt, erhalten Sie ein NDA zur Unterzeichnung. Nach unterschriebenem NDA stellen wir Ihnen den Zugang zum Datenraum zur Verfügung. Wird der Zugang abgelehnt, sollten Sie dies in Ihrer Investitionsentscheidung berücksichtigen.


Individuelle Berechnung Ihrer Rendite auf Basis der Finanzplanung und Ihres Investitionsbetrags – inklusive transparenter Zinsgrafik zur Darstellung der Auszahlung über die gesamte Laufzeit:
Calculate individual return